索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李翠,刘丽云,王治平.中介素对冠状动脉粥样硬化性心脏病的作用机制研究[J].国际心血管病杂志,2016,03:164-166,182.
点击复制

中介素对冠状动脉粥样硬化性心脏病的作用机制研究(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年03期
页码:
164-166,182
栏目:
综述
出版日期:
2016-05-20

文章信息/Info

Title:
-
作者:
李翠; 刘丽云; 王治平
046000 山西,长治医学院附属和平医院心血管内科
Author(s):
-
关键词:
中介素; 肾上腺髓质素2; 冠状动脉粥样硬化性心脏病; 作用机制
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.03.010
文献标识码:
-
摘要:
中介素又称肾上腺髓质素2,是一种新发现的降钙素基因相关肽超家族成员,具有广泛的生物学效应,尤其对心、肺、肾等脏器有重要的调节作用。该文主要介绍中介素的生物学特性、分布、受体及其对冠状动脉粥样硬化性心脏病的作用机制。
Abstract:
-

参考文献/References

[1] Roh J,Chang CL,Bhalla A,et al.Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J].J Biol Chem,2004,279(8):7264-7274.
[2] Takei Y,Inoue K,Ogoshi M,et al.Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator[J].FEBS Lett,2004,556(1-3):53-58.
[3] Yang JH,Jia YX,Pan CS,et al.Effects of intermedin(1-53)on cardiac function and ischemia/reperfusion injury in isolated rat hearts[J].Biochem Biophys Res Commun,2005,327(3):713-719.
[4] Holmes D,Campbell M,Harbinson M,et al.Protective effects of intermedin on cardiovascular,pulmonary and renal diseases:comparison with adrenomedullin and CGRP[J].Curr Protein Pept Sci,2013,14(4):294-329.
[5] Hong Y,Hay DL,Quirion R,et al.The pharmacology of adrenomedullin 2/intermedin[J].Br J Pharmacol,2012,166(1):110-120.
[6] 李益萍,王肖龙.氧化低密度脂蛋白对泡沫细胞形成的作用[J].国际心血管病杂志,2015,42(5):335-337.
[7] Zhang X,Gu L,Chen X,et al.Intermedin ameliorates atherosclerosis in ApoE null mice by modifying lipid profiles[J].Peptides,2012,37(2):189-193.
[8] Dai XY,Cai Y,Mao DD,et al.Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice[J].J Mol Cell Cardiol,2012,53(4):509-520.
[9] Wang Y,Yang R,Chen X,et al.Intermedin inhibits uptake of oxidized LDL via CD36 pathway in RAW264.7 cells[J].Pharmazie,2014,69(6):473-476.
[10] Dai XY,Cai Y,Sun W,et al.Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA[J].Cardiovasc Res,2014,101(2):297-305.
[11] Kobayashi Y,Liu YJ,Gonda T,et al.Coronary vasodilatory response to a novel peptide,adrenomedullin 2[J].Clin Exp Pharmacol Physiol,2004,31(Suppl 2):S49-S50.
[12] Teng X,Bian Y,Cai Y,et al.Downregulation of endogenous intermedin augmented myocardial injury in rats with ischemia/reperfusion[J].Horm Metab Res,2013,45(3):206-212.
[13] Zhang HY,Jiang W,Liu JY,et al.Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model[J].Hypertens Res,2009,32(10):861-868.
[14] 卫 雷,成尚霖,马 捷.IMD对缺血-再灌注心肌保护ATP敏感性钾通道的作用研究[J].中国医疗前沿,2011,6(22):21-22.
[15] 齐永芬.Intermedin/adrenomedullin 2抗心肌缺血再灌注损伤的作用机制[J].中国病理生理杂志,2012,28(11):2023.
[16] Zhao L,Peng DQ,Zhang J,et al.Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion[J].Peptides,2012,33(2):329- 335.
[17] Song JQ,Teng X,Cai Y,et al.Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53)protection against myocardial apoptosis induced by ischemia/reperfusion[J].Apoptosis,2009,14(11):1299-1307.
[18] 杜秋香,岳 维,王英元.中介素对大鼠急性心肌缺血损伤的作用及机制[J].法医学杂志,2011,27(3):164-168.
[19] 杜秋香,王进亮,孙俊红,等.中介素(IMD)对大鼠心肌细胞缺氧-复氧损伤的作用[J].中国法医学杂志,2014,21(3):231-234.
[20] Yang JH,Cai Y,Duan XH,et al.Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensinⅡ[J].Regul Pept,2009,158(1-3):19-25.
[21] Yang X,Zhang H,Jia Y,et al.Effects of intermedin1-53 on myocardial fibrosis[J].Acta Biochim Biophys Sin(Shanghai),2013,45(2):141-148.
[22] Qin YW,Teng X,He JQ,et al.Increased plasma levels of intermedin and brain natriuretic peptide associated with severity of coronary stenosis in acute coronary syndrome[J].Peptides,2013,42:84-88.
[23] Lv Z,Wu K,Chen X,et al.Plasma intermedin levels in patients with acute myocardial infarction[J].Peptides,2013,43:121-125.
[24] Tang B,Zhong Z,Shen HW,et al.Intermedin as a prognostic factor for major adverse cardiovascular events in patients with ST-segment elevation acute myocardial infarction[J].Peptides,2014,58:98-102.

备注/Memo

备注/Memo:
基金项目:长治医学院科技创新团队项目(CX2014-01) 作者单位:046000 山西,长治医学院附属和平医院心血管内科 通信作者:王治平,Email:ganendexin7463@163.com
更新日期/Last Update: 2016-05-20